Clobetazol Propionato Mintlab Uses, Dosage, Side Effects and more
Clobetazol Propionato Mintlab is under investigation for the treatment of Scleroderma. Clobetazol Propionato Mintlab has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetazol Propionato Mintlab |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Chile |
| Last Updated: | January 7, 2025 at 1:49 am |
Clobetazol Propionato Mintlab Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
